Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results And Business Update.pdf

2023-03-30_Molecular_Templates_Inc_Reports_Fourth_Quarter_120.pdf
Preview of Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update
🔗 Source: d1io3yog0oux5.cloudfront.net
📊 Size: 94 KB
📄 Pages: 7 pages
⬇️ Downloads: 19

Summary

Key Highlights:

Strategic Reprioritization: Molecular Templates (MTM) is reducing its workforce by approximately 50% to focus on three core clinical development programs: MT-6402, MT-8421, and MT-0169. This shift also involves ceasing the MT-5111 program and concentrating preclinical efforts related to Bristol Myers Squibb collaboration.
Clinical Program Updates:
MT-6402 (PD-L1 targeting ETB): Demonstrates potent PD effects, monotherapy activity in heavily pre-treated patients, and a PR in a NPC patient with low HLA-A02 expression, suggesting T-cell activation through clearance of PD-L1+ immune cells.
MT-8421 (CTLA-4 targeting ETB): An IND was accepted in March 2023, paving the way for a phase I study focusing on eliminating CTLA-4+ Tregs in the tumor microenvironment without causing irAEs.
MT-0169 (CD38 targeting ETB): Shows promising results with no observed capillary leak syndrome or other off-target effects. A VGPR was achieved in a patient with extramedullary IgA myeloma.
* Safety and Efficacy Validation: The ETB platform continues to demonstrate clinical validation, showcasing both safety and efficacy across multiple programs.

Description

Molecular Templates, Inc. shifts focus to clinical development of key drugs (MT-6402, MT-8421, MT-0169) and preclinical BMS collaboration, downsizing workforce to extend financial resources. Announcement follows Q4 2022 financial results.

Technical Information

  • File Format: PDF
  • File Size: 94 KB
  • Pages: 7
  • Language: EN
  • Total Downloads: 19
  • Last Updated: 2 days ago

Document Overview

This PDF document about Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update.

Related Topics

If you're interested in Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update, you might also want to explore:

Download Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update eBooks for free and learn more about Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update. These books contain exercises and tutorials to improve your practical skills, at all levels!

Not satisfied with this document? We have related documents to Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update, try searching with similar keywords: Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update, 9/26/19 – Precision Optics Reports Fourth Quarter and Fiscal Year 2019 Financial Results, Aviso nº 11808/2022 - 09/06/2022 + Retificação Despacho n.º 9545/2022 de 03/08/2022, Apple Reports Third Quarter Results, T Mobile Usa Reports Second Quarter 2012 Operating Results, Vodacom Group Limited's trading update for the quarter ended 31 December 2022 (102 Kb), Share Ebook Strategies And Applications In Quantum Chemistry From Molecular Astrophysics To Molecular Engineering Topics In Molecular Organization An, Sidus Space: Q3 2023 Financial Results and Business Update

You can download PDF versions of the user's guide, manuals and ebooks about Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update, you can also find and download for free A free online manual (notices) with beginner and intermediate, Downloads Documentation, You can download PDF files (or DOC and PPT) about Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update for free, but please respect copyrighted ebooks.